Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Some individuals achieve their goals at 5mg or 7.5mg and do not require further escalation
Combining EmSculpt Neo with weight management treatments like Semaglutide and Tirzepatide offers a holistic approach to achieving peak physical fitness and enhancing overall health. Dr
The compound delivers consistent, significant, and measurable weight reduction that often begins within the first week of treatment
In a large phase 3 obesity trial (ACHIEVE-1), orforglipron at daily doses of 3, 12 and 36 mg caused approximately: Diarrhoea: 1926% of participants (vs 9% on placebo) Nausea: 1318% (vs 2% on placebo) Constipation: 817% (vs 4% on placebo) Vomiting: 514% (vs 1% on placebo) Across multiple studies, 617% of people stopped treatment because of side effects, mostly gut-related symptoms
